The Future of Wellbeing

Glycobiology has emerged as a new technology only in the past decade. So what’s in store for the future?

For Mannatech it’s a form of “genetic blueprinting”. “We are currently developing the first generation of nutrigenetics/nutrigenomics tools, to help guide consumers toward specific health products in our range,” explains Robert Sinnott (chief science officer and vice president of research and development of US based Mannatech, a company that specializes in glyconutritional science).

Using these tools, an individual will be able to take a DNA test to determine if they have genetic factors which put them at a higher risk of certain health conditions, such as cardiovascular disease and immune disorders.

“Based on this profile, they can then follow recommendations for proven ways to reduce these risk factors, such as increasing intake of certain nutritional substances,” Sinnott says.

Human genetic constitution has changed relatively little in 40,000 years, but what we eat and how we live has changed dramatically, which is why we sometimes need to turn to supplementation to redress the balance. Sinnott aggress, “While you may already take vitamins, mineral, amino acids and enzymes, glyconutritional supplements provide the “missing link” that will help you preserve your vitality.”

Mannatech was founded in November 1993 by current CEO and Chairman Sam Caster. During its first two years, the company focused on products that contained aloe vera extract. Mannatech announced its flagship product, Ambrotose, 1996 based on the discovery that the body’s immune system needs eight plant-based sugars – also known as glyconutrients – to function properly.